Revolution Medicines Inc.

41.06
0.33 (0.81%)
At close: Jan 28, 2025, 2:41 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -436.37M -248.71M -187.09M -108.16M -47.66M -41.79M -31.13M
Depreciation & Amortization 9.31M 9.66M 7.33M 6.54M 3.34M 1.76M 1.19M
Stock-Based Compensation 61.77M 31.20M 20.72M 8.89M 3.16M 855.00K 141.00K
Other Working Capital 864.00K -22.03M -1.66M -8.61M -14.09M 37.95M 2.68M
Other Non-Cash Items -18.13M -2.64M 3.13M 1.34M 4.75M 2.12M 549.00K
Deferred Income Tax -3.91M -419.00K n/a -375.00K -4.37M 201.00K n/a
Change in Working Capital 36.75M -13.49M 8.72M -8.30M -8.83M 38.06M 4.65M
Operating Cash Flow -350.57M -224.40M -147.18M -100.06M -49.62M 1.21M -25.15M
Capital Expenditures -7.73M -10.82M -6.53M -2.93M -2.59M -1.50M -1.57M
Acquisitions n/a 13.30M 135.59M 231.30M 196.00K 160.00K n/a
Purchase of Investments -1.06B -612.77M -671.34M -544.13M -172.27M n/a n/a
Sales Maturities Of Investments 724.05M 599.47M 535.75M 312.83M 66.69M n/a n/a
Other Investing Acitivies -1 -13.30M -135.59M -231.30M 6.00M n/a n/a
Investing Cash Flow -342.60M -24.12M -142.12M -234.23M -101.97M -1.34M -1.57M
Debt Repayment n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased 3.32M n/a n/a n/a -45.00K -131.00K n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 843.44M 3.39M 2.94M 2.71M 98.66M 60.85M 45.25M
Financial Cash Flow 1.23B 301.43M 294.18M 422.78M 98.66M 60.85M 22.66M
Net Cash Flow 536.03M 52.91M 4.88M 88.48M -52.93M 60.72M -4.06M
Free Cash Flow -358.30M -235.22M -153.71M -103.00M -52.20M -286.00K -26.72M

Create Price Alert on RVMD

Your price alert will notify you when the stock price is above 41.06.

Add to Watchlist